Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | LTA4H | P09960 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.50 |
| ▸ | BAX | Q07812 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24322042 | 1.00 | HTT (0.62) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL20419433 | 1.00 | HTT (0.62) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL537243 | 0.95 | HTT (0.57) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL16361074 | 0.95 | HTT (0.57) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL2058591 | 0.95 | HTT (0.57) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| Diphenylether SCHEMBL9751563 | 0.95 | LTA4H (0.57) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| Biphenyl SCHEMBL312988 | 0.93 | HTT (0.59) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL12355 | 0.93 | HTT (0.69) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL425356 | 0.93 | HTT (0.69) | HTTSMN1; SMN2LTA4HTSHRTEAD4 | |
| SCHEMBL17081753 | 0.93 | HTT (0.69) | HTTSMN1; SMN2LTA4HTSHRTEAD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190264045-A1 | POLY-(ARYL-ETHER-KETONE) (PAEK) COMPOSITION WITH A LOW CONTENT OF VOLATILE COMPOUNDS AND USE OF SAME IN A SINTERING METHOD | ARKEMA FRANCE (FR) | 2019-08-29 | — | — | US | disclosed |
| US-RE47556-E1 | Optical element compound, optical material, and optical element | CANON KABUSHIKI KAISHA (JP) | 2019-08-06 | — | — | US | disclosed |
| US-8829230-B2 | Optical element compound, optical material, and optical element | CANON KABUSHIKI KAISHA (JP) | 2014-09-09 | — | — | US | disclosed |
| US-20140031582-A1 | OPTICAL ELEMENT COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2014-01-30 | — | — | US | disclosed |
| US-8569541-B2 | Optical element compound, optical material, and optical element | CANON KABUSHIKI KAISHA (JP) | 2013-10-29 | — | — | US | disclosed |
| US-20110288330-A1 | OPTICAL ELEMENT COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288330-A1 | OPTICAL ELEMENT COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CENPE, AXIN2, CCNE2 | HTT 3535/4885SMN1; SMN2 1377/4885LTA4H 2503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.